candoxatril has been researched along with valine in 1 studies
| Studies (candoxatril) | Trials (candoxatril) | Recent Studies (post-2010) (candoxatril) | Studies (valine) | Trials (valine) | Recent Studies (post-2010) (valine) |
|---|---|---|---|---|---|
| 62 | 29 | 5 | 15,465 | 1,176 | 3,932 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Armstrong, SR; Budman, J; Cheruvu, M; Hegde, LG; Hegde, SS; Hill, CM; Klein, U; Lane, CE; Olsufka, R; Park, T; Renner, T; Sandvik, ER; Thibodeaux, H; Yu, C | 1 |
1 other study(ies) available for candoxatril and valine
| Article | Year |
|---|---|
Concomitant angiotensin AT1 receptor antagonism and neprilysin inhibition produces omapatrilat-like antihypertensive effects without promoting tracheal plasma extravasation in the rat.
Topics: Angioedema; Animals; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Indans; Male; Neprilysin; Propionates; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Tetrazoles; Thiazepines; Valine; Valsartan | 2011 |